Proliferative diabetic retinopathy Eye Diseases Proliferative diabetic retinopathy
Conditions
Interventions
Eligible eyes are randomized into two treatment groups using a random sampling envelope technique. For all participants, once baseline parameters have been obtained, laser eye therapy is given. The ey
Sponsors
Universiti Sains Malaysia
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged 40 years and over 2. Newly diagnosed proliferative diabetic retinopathy among diabetic patients
Exclusion criteria
Exclusion criteria: 1. On regular eye drops medication (eg topical antiglaucoma drugs) 2. Poor media that obscuring view of delivering laser photocoagulation to the retina such as corneal opacity and preretinal or vitreous hemorrhage obscuring view of retina 3. Previous history of intraocular surgery or ocular trauma including chemical, thermal or radiation injury 4. Contact lens wearer 5. Previous history of laser photocoagulation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Schirmer test value is measured using the Schirmer test at baseline and 12 weeks 2. Tear film break-up time (TBUT) is determined by measuring the interval between the last complete blink and the first appearance of a dry spot in the stained cornea at baseline and 12 weeks 3. Ocular Surface Disease Index (OSDI) score is measured using the OSDI questionnaire at baseline and 12 weeks | — |
Countries
Malaysia
Outcome results
None listed